Menveo shortage — CH supply status & alternatives

Menveo

—

🇦🇺 AUST R 393321 · GlaxoSmithKline Australia Pty Ltd

In supply · Australia

Menveo Pulver und Lösung

In supply · 🇦🇺 Australia · short in🇨🇭 CH

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Menveo
Brand names	Menveo Pulver und Lösung
Therapeutic category	Auto-created by Swissmedic scraper
Controlled substance	No

Marketing-authorisation holders	GlaxoSmithKline Australia Pty Ltd, GlaxoSmithKline Biologicals SA, GSK Vaccines S.r.l., GLAXOSMITHKLINE INC

Registrations on file	6

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇫🇷 FR

€50.52

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Verified timeline regulator events

🇨🇭 1 July 2026

medium reported

🇨🇭 28 June 2026

medium reported

🇨🇭 27 June 2026

medium reported

🇨🇭 26 June 2026

medium reported

🇨🇭 22 June 2026

medium reported

🇨🇭 21 June 2026

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders6 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
MENVEO Meningococcal Oligosaccharide CRM197 solution for	—	—	🇦🇺 AU	GlaxoSmithKline Australia Pty Ltd	Active
MENVEO meningococcal oligosaccharide CRM197 conjugate vaccine	—	—	🇦🇺 AU	GlaxoSmithKline Australia Pty Ltd	Active
Menveo	10; 5; 5; 5ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	injection	🇺🇸 US	GlaxoSmithKline Biologicals SA	Active
Menveo	—	kit	🇺🇸 US	GlaxoSmithKline Biologicals SA	Active
Menveo	—	—	🌐 EU	GSK Vaccines S.r.l.	Active
MENVEO	—	solution	🇨🇦 CA	GLAXOSMITHKLINE INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.